Champions Oncology, Inc. (CSBR) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

Earnings Reports

• Champions Oncology (CSBR) Q4 2026: Services Revenue Climbs 12% as Data Licensing Remains Volatile
  July 28, 2026
• Champions Oncology (CSBR) Q3 2026: Core Study Revenue Climbs 32% as Data Platform Awaits Inflection
  March 13, 2026
• Champions Oncology (CSBR) Q2 2026: Gross Margin Expands to 52% as Radiolabeling and Data Platform Drive Leverage
  December 17, 2025
• Champions Oncology (CSBR) Q1 2026: Gross Margin Drops to 43% as Radio Labeling Costs Weigh on Profitability
  October 15, 2025

Browse all companies